ロード中...
LSD1/KDM1A inhibitors in clinical trials: advances and prospects
Histone demethylase LSD1 plays key roles during carcinogenesis, targeting LSD1 is becoming an emerging option for the treatment of cancers. Numerous LSD1 inhibitors have been reported to date, some of them such as TCP, ORY-1001, GSK-2879552, IMG-7289, INCB059872, CC-90011, and ORY-2001 currently und...
保存先:
| 出版年: | J Hematol Oncol |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6894138/ https://ncbi.nlm.nih.gov/pubmed/31801559 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13045-019-0811-9 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|